Summary
An investigation of the role of copper in bone metabolism was undertaken. Explanted calvaria from 6-day-old mice were grown for 48 h in medium with and without the addition of copper sulfate. Active resorption was found to be significantly inhibited in the presence of copper sulfate concentrations of 10−6M and above. Copper sulfate concentrations of 10−5M and above inhibited hydroxyproline, protein, and DNA synthesis. Lower concentrations were ineffective. The effect of 5 × 10−6M copper sulfate on resorption was reversible. Several other compounds were tested for similar effects and at 5 × 10−6M were found to inhibit bone resorption in the order: copper sulfate > brown gold chloride > sodium aurothiomalate > zinc sulfate > sodium sulfate. The copper sulfate effect was twice that of sodium aurothiomalate, and sodium sulfate was not significantly inhibitory. The results suggest that the high serum copper levels associated with rheumatoid arthritis may reflect the activity of a hypothetical control mechanism of bone resorption. In the diseased state this would act to restore the normal rate of bone resorption.
Similar content being viewed by others
References
Scudder, P.R., Al-Timimi, D., McMurray, W., White, A.G., Zoob, B.C., Dormandy, T.L.: Serum copper and related variables in rheumatoid arthritis, Ann. Rheum. Dis.37:67–70, 1978
Scudder, P.R., McMurray, W., White, A.G., Dormandy, T.L.: Synovial fluid copper and related variables in rheumatoid and degenerative arthritis, Ann. Rheum. Dis.37:71–72, 1978
Aaseth, J., Munthe, E., Førre, O., Steinnes, E.: Trace elements in serum and urine of patients with rheumatoid arthritis, Scand. J. Rheumatol.7:237–240, 1978
Sorenson, J.P.J.: Copper chelates as possible active forms of antiarthritic agents, J. Med. Chem.19:135–148, 1976
Walker, W.R., Keats, D.M.: An investigation of the therapeutic value of the “copper bracelet”—dermal assimilation of copper in arthritic/rheumatoid conditions, Agents Actions6:454–459, 1976
Gray D.H., Katz, J.M., Speak K.: The effects of varying oxygen tensions upon bone resorptionin vitro, J. Bone Joint Surg. (Am)60:575–578, 1978
Stegemann, H., Stalder, K.: Determination of hydroxyproline, Clin. Chim. Acta18:267–273, 1967
Barnicot, N.A.: The supravital staining of osteoclasts with neutral red; their distribution on the parietal bone of normal, growing mice, and a comparison with the mutants grey-lethal and hydrocephalus-3, Proc. R. Soc. Lond. [Biol.]134:467–485, 1947
Oster, A., Salgo, M.P.: Copper in mammalian reproduction, Adv. Pharmacol. Chemother.14:327–409, 1977
Sigler, J.M., Bluhm, G.B., Duncan, H., Sharp, J.T., Ensign, D.W., McCrum, W.R.: Gold salts in the treatment of rheumatoid arthritis, Ann. Intern. Med.80:21–26, 1974
Report of the task group on reference man. International Commission on Radiological Protection. Publication 23. Pergamon Press Ltd., Oxford, 1973
Maddox, I.S.: The role of copper in prostaglandin synthesis, Biochim. Biophys. Acta306:74–81, 1973
Dietrich, J.W., Raisz, L.G.: Prostaglandin in calcium and bone metabolism, Clin. Orthop.111:228–237, 1975
Rayton, J.K., Harris, E.D.: Induction of lysyl oxidase with copper: properties of anin vitro system, J. Biol. Chem.254:621–626, 1979
Carnes, W.H.: Role of copper in connective tissue metabolism, Fed. Proc.30:995–1000, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, T., Katz, J.M. & Gray, D.H. Inhibition of active bone resorption by copper. Calcif Tissue Int 33, 35–39 (1981). https://doi.org/10.1007/BF02409410
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02409410